CN Stock MarketDetailed Quotes

600062 China Resources Double-Crane Pharmaceutical

Watchlist
  • 19.15
  • -0.19-0.98%
Not Open Jan 8 15:00 CST
19.89BMarket Cap14.76P/E (TTM)

China Resources Double-Crane Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

China Resources Double-Crane Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Apr 26, 20242024/Q12.835B / 2.876B--
Oct 30, 20192019/Q32.541B / 2.364B--
Aug 22, 20192019/Q22.233B / 2.148B--
Apr 27, 20192019/Q12.633B / 1.802B--
DatePeriodRevenue/EstimateEarnings Call
Apr 26, 20242024/Q12.835B / 2.876B--
Oct 30, 20192019/Q32.541B / 2.364B--
Aug 22, 20192019/Q22.233B / 2.148B--
Apr 27, 20192019/Q12.633B / 1.802B--
--------

Unlock Free Earnings Estimates

China Resources Double-Crane Pharmaceutical Earnings Reports

  • Announcement of China Resources Shuanghe on the main operating data for the 1st to 3rd quarter of 2024

    Oct 25, 2024 12:00 ET

  • China Resources Shuanghe 2024 Third Quarter Report

    Oct 25, 2024 12:00 ET

  • China Resources Double-Crane Pharmaceutical 2024 Semi-Annual Report

    Aug 22, 2024 12:00 ET

  • china resources double-crane pharmaceutical 2024 interim report summary

    Aug 22, 2024 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jan 8, 2025

    Strong Buy

    • Strong Buy

      80.00%

    • Buy

      20.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme ShangHai Stock Connect
    ShangHai Stock Connect
    Intraday+0.26%
    State-owned Enterprise Reform
    State-owned Enterprise Reform
    Intraday+0.19%
    Artemisinin
    Artemisinin
    Intraday+0.17%